XENON PHARMACEUTICALS INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-30.7M | $-23.0M | $-15.8M | $13.0M | $12.0M | $-4.3M |
| Depreciation & Amortization | $649.0K | $864.0K | $1.0M | $738.0K | $705.0K | $786.0K |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $2.2M | $2.2M | $3.7M | $760.0K | $575.0K | $406.0K |
| Net Cash from Operating Activities | $-28.7M | $-19.6M | $-18.1M | $266.0K | $-3.3M | $45.6M |
| Investing Activities | ||||||
| Capital Expenditures | $315.0K | $279.0K | $551.0K | $1.5M | $156.0K | $526.0K |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $24.3M | — | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $7.1M | — | — | — | — | — |
| Net Change in Cash | $3.4M | $-41.6M | $-13.4M | $34.1M | $-22.2M | $46.2M |
| Free Cash Flow | $-29.0M | $-19.8M | $-18.7M | $-1.3M | $-3.5M | $45.0M |